| 영문 | alpha-fetoprotein | 한글 | 알파태아단백 |
|---|---|---|---|
| 설명 | 태아의 간조직이나 소화기관에서 만들어지는 단백질. 태아기나 임산부에서 정상적으로 존재한다. 그러나 간암세포나 생식세포에 관련된 종양에서도 만들어져 이런 질병이 존재할 때에는 임산부나 태아가 아니더라도 조직이나 혈액에 나타나게 된다. 임상적으로는 간암이나 생식세포 종양의 발견과 치료효과 판정에 이용되고, 또 임신 16~18주에 산모의 혈액에서 이단백질의 양을 측정하여 태아의 비정상적인 발달을 발견할 수 있다. |
||
| 영문 | alpha particles | 한글 | 알파입자 |
|---|---|---|---|
| 설명 | 원자에 정상보다 과다, 과소한 중성자나 양자를 가지고 있는 경우에 원자가 안정되기 위해서 붕괴가 생긴다. 이런 붕괴에는 다음과 같은 3가지 방법이 있다. 알파－붕괴는 알파입자를 방출하여 안정되는 법, 즉 원자번호는 2씩 감소하고 질량수는 4씩 감소한다. 알파입자란 알파붕괴에 의해서 생기는 헬륨의 핵과 같은 입자를 말한다. |
||
| AFAFP | amniotic fluid alpha-fetoprotein |
|---|---|
| AFP | alpha-fetoprotein; anterior faucial pillar; atypical facial pain |
| HAFP | human alpha-fetoprotein |
| MSAFP, MS-AFP | maternal serum alpha-fetoprotein |
| FP | false positive; family physician; family planning; family practice; family practitioner; Fanconi pan... |
| alpha-FP | ALPHA-Fetoprotein |
|---|---|
| AF-AFP | Amniotic fluid alpha-fetoprotein |
| AFP | Anti-alpha-fetoprotein |
| HAFP | Human alpha-fetoprotein |
| AFP | Serum-alpha 1-fetoprotein |
| alpha-fetoprotein | <protein, tumour marker> A protein substance that is normally produced by the liver cells. It is one of the first alpha-globulins to appear in mammalian sera during development of the embryo and the dominant serum proteins in early embryonic life. They reappear in the adult serum during certain pathologic states. Measurement of the alpha-fetoprotein level in the bloodstream has been used as a early detection test for some forms of cancer (hepatocellular carcinoma). Alpha-fetoprotein can also be an important marker in the fluid obtained by amniocentesis for the prenatal diagnosis of anencephaly and other open neural tube defects such as spina bifida. Elevated in: wrong dates for a pregnancy, multiple gestation, midline closure (neural-tube) defects, encephalocele, anencephaly, liver tumours, hepatoblastoma, haemangioendothelioma (occasionally, mild), hepatocellular carcinoma (HCC, hepatoma). The level produced by liver tumours (hepatomas), germ cell tumours (teratocarcinoma and embryonal cell carcinomas) permits the monitoring of response to treatment of these tumours. Decreased in: wrong dates for a pregnancy, chromosome abnormality (including Down syndrome) Acronym: AFP (27 Jun 1999) |
|---|---|
| maternal serum alpha-fetoprotein | A plasma protein, alpha-fetoprotein (afp) is normally produced by the foetus. The level of afp in the blood serum of pregnant women provides a screening test for open neural tube defects (anencephaly and spina bifida) and for down syndrome (and other chromosome abnormalities). The maternal serum afp (msafp) tends to be unusally high with open neural tube defects and unsually low with down syndrome. (12 Dec 1998) |
| a fetoprotein | A protein normally produced during the 12th to 15th week of gestation, decreasing thereafter, but appearing in the blood in certain tumours, such as embryonal carcinomas of the testis and ovary, hepatoma, and less often in patients with carcinomas of the pancreas, stomach, colon, or lung. When present, a useful marker in following the course of a tumour. (05 Mar 2000) |
| alpha, alpha-phosphotrehalase | <enzyme> Forms glucose plus glucose-6-phosphate Registry number: EC 3.2.1.93 Synonym: trehalose-6-phosphate hydrolase, phospho-alpha(1,1)glucosidase, trea gene product, trec gene product (26 Jun 1999) |
| alpha,alpha-trehalose phosphorylase | <enzyme> Chemical name: alpha-d-glucopyranosyl-alpha-d-glucopyranose orthophosphate glucosyltransferase Registry number: EC 2.4.1.64 Synonym: trehalose phosphorylase (26 Jun 1999) |
| alpha-dextrin endo-1,6-alpha-glucosidase | <enzyme> An enzyme with action similar to that of isoamylase; it cleaves 1,6-alpha-glucosidic linkages in pullalan, amylopectin, and glycogen, and in alpha-and beta-amylase limit-dextrins of amylopectin and glycogen. Compare: isoamylase. Synonym: limit dextrinase, pullulanase, R enzyme. (05 Mar 2000) |
| alpha-hydroxymethyl-alpha'-(N-acetylaminomethylene)succinic acid hydrolase | <enzyme> Involved in degradation of vitamin b6; forms acetic acid plus ammonia plus carbon dioxide plus alpha-hydroxymethyl-succinic monoaldehyde Registry number: EC 3.5.1.- Synonym: compound b hydrolase (26 Jun 1999) |
| cholesterol-5 alpha,6 alpha-epoxide hydrase | <enzyme> Aspect of epoxide hydrolase, EC 3.3.2.3 Pharmacological action: carcinogen Registry number: EC 3.3.2.- Synonym: cholesterol epoxide hydrase, cholesterol epoxide hydrolase (26 Jun 1999) |
| CMP-acetylneuraminate-alpha-N-acetylneuramide alpha-2,8-sialyltransferase | <enzyme> Forms ganglioside gd3 Registry number: EC 2.4.99.8 Synonym: cmp-n-acetylneuraminate-gm3 sialyltransferase, gm3-sialosyltransferase, gd3 synthase, gd3-synthase, cmp-n-acetylneuraminate-(n-acetylneuraminyl)-d-galactosyl-d-glucosylceramide sialyltransferase, sialyltransferase II, st II, g(m3) alpha-2,8-sialyltransferase, st8sia I, stii enzyme, stiii enzyme, gt3 synthase (26 Jun 1999) |
| CMP-N-acetylneuraminate-alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase | <enzyme> Enzyme from foetal calf liver; forms branched tetrasaccharide, neuac-alpha2-3gal-beta1-3(neuac-alpha2-6)galnac of fetuin Registry number: EC 2.4.99.3 Synonym: cmp-aag-sialyltransferase, st6galnaci, galnac 2,6-sialyltransferase (26 Jun 1999) |
| NAD 3 alpha-hydroxy-5 alpha-pregnan-20-one-oxidoreductase | <enzyme> From rat liver microsomes Registry number: EC 1.1.1.- Synonym: nad-3-hp-20-oor (26 Jun 1999) |
| 1,4-alpha-d-glucan 6-alpha-d-glucosyltransferase | A glucosyltransferase that transfers an alpha-glucosyl residue in a 1,4-alpha-glucan to the primary hydroxyl group of glucose in a 1,4-alpha-glucan. See: 1,4-alpha-d-glucan branching enzyme. Synonym: oligoglucan-branching glycosyltransferase. (05 Mar 2000) |
| 1,4-alpha-glucan 6-alpha-glucosyltransferase | <enzyme> From aspergillus niger and oryzae Registry number: EC 2.4.1.24 (26 Jun 1999) |
| 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid | <chemical> A stable prostaglandin endoperoxide analog which serves as a thromboxane mimetic. Its actions include mimicking the hydro-osmotic effect of vasopressin and activation of phospholipase c. Pharmacological action: vasoconstrictor agents. Chemical name: 5-Heptenoic Acid, 7-(6-(3-Hydroxy-1-Ocentyl)-2-Oxabicyclo(2.2.1)hept-5-yl)-, (1R-(1alpha,4alpha,5 beta(Z),6alpha(1E,3S*)))- (12 Dec 1998) |
| 5 alpha-3 alpha-hydroxysteroid dehydrogenase | <enzyme> Androsterone can be substrate Registry number: EC 1.1.1.50 Synonym: 3 alpha-hydroxysteroid dehydrogenase, 3 alpha-hydroxysteroid oxidoreductase, 3 oc-hydroxysteroid dehydrogenase (26 Jun 1999) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|